Although viral vector-based gene delivery is not cancer tissue-specific, several studies have demonstrated that IFNβ gene therapy using adenoviral vectors is effective in several cancers such as ovarian cancer [11], bladder cancer [12], glioma [13], and lung cancer [14]. Here, IFNB1 is linked to glioma.